Agenda
DAY 1
DAY 2
Session II
HER 2+
Friday, September 12, 2025
1:45 pm
—
3:10 pm
Credits Available
View Full Attendance Credit

Session Moderator(s)
PRESENTATION IN THIS SESSION
Session Introduction
Optimizing Treatment for Early Stage HER2 Positive Breast Cancer
Optimizing Sequencing of Therapy for Metastatic HER2 Positive Breast Cancer
What's on the Horizon: Novel Strategies in HER2 Positive Breast Cancer
Heather L. McArthur, MD, MPH, FASCO
Audience Q&A and Panel Discussion
Ana C. Garrido-Castro, MD; Heather L. McArthur, MD, MPH; Ana C. Sandoval Leon, MD